Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 7.20
-0.15 (-2.04%)
At close: Aug 12, 2026
BUL:THQM Ratios and Metrics
Market cap in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,402 | 1,761 | 1,648 | 1,508 | 1,360 | 1,259 | |
Market Cap Growth | -13.52% | 6.85% | 9.28% | 10.88% | 8.06% | 10.33% |
Enterprise Value | 1,411 | 1,773 | 1,659 | 1,520 | 1,372 | 1,271 |
Last Close Price | 13.84 | 17.39 | 16.27 | 15.39 | 13.88 | 12.85 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 234.52 | 292.92 | 367.12 | 443.67 | 487.62 | 901.80 |
PS Ratio | 20.23 | 27.52 | 31.02 | 31.10 | 31.53 | 29.67 |
PB Ratio | 11.88 | 15.10 | 15.06 | 14.37 | 13.39 | 12.74 |
P/TBV Ratio | 12.27 | 15.59 | 15.46 | 14.87 | 13.91 | 13.20 |
P/FCF Ratio | 466.02 | 711.08 | 1379.40 | 1579.55 | 1544.21 | 2797.58 |
P/OCF Ratio | 378.95 | 492.41 | 490.15 | 526.15 | 552.80 | 622.30 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 20.16 | 27.70 | 31.22 | 31.33 | 31.81 | 29.95 |
EV/EBITDA Ratio | 138.15 | 187.88 | 213.01 | 223.12 | 215.21 | 239.71 |
EV/EBIT Ratio | 214.54 | 270.09 | 314.84 | 379.07 | 450.56 | 872.30 |
EV/FCF Ratio | 469.19 | 715.73 | 1388.21 | 1591.28 | 1557.77 | 2824.31 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.10 | 0.10 | 0.11 | 0.12 | 0.13 |
Debt / EBITDA Ratio | 0.94 | 1.25 | 1.43 | 1.64 | 1.79 | 2.36 |
Debt / FCF Ratio | 3.17 | 4.75 | 9.31 | 11.70 | 13.40 | 27.75 |
Net Debt / Equity Ratio | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 |
Net Debt / EBITDA Ratio | 1.07 | 1.12 | 1.41 | 1.63 | 1.83 | 2.35 |
Net Debt / FCF Ratio | 3.14 | 4.27 | 9.20 | 11.64 | 13.24 | 27.62 |
Asset Turnover | 0.52 | 0.47 | 0.42 | 0.40 | 0.36 | 0.36 |
Inventory Turnover | 0.55 | 1.07 | 1.05 | 2.41 | 1.03 | 2.77 |
Quick Ratio | 4.12 | 3.39 | 3.83 | 3.99 | 3.77 | 3.63 |
Current Ratio | 5.34 | 4.43 | 5.14 | 5.28 | 4.84 | 4.49 |
Return on Equity (ROE) | 5.16% | 5.32% | 4.19% | 3.29% | 2.78% | 1.43% |
Return on Assets (ROA) | 3.05% | 3.03% | 2.62% | 2.07% | 1.60% | 0.78% |
Return on Invested Capital (ROIC) | 4.62% | 4.80% | 3.98% | 3.07% | 2.42% | 1.18% |
Return on Capital Employed (ROCE) | 5.40% | 5.50% | 4.70% | 3.70% | 2.90% | 1.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.42% | 0.34% | 0.27% | 0.22% | 0.21% | 0.11% |
FCF Yield | 0.21% | 0.14% | 0.07% | 0.06% | 0.07% | 0.04% |
Buyback Yield / Dilution | 1.61% | - | -3.38% | - | - | -37.37% |